Search by Topic
Join our mailing list!
Thanks! You've been successfully signed up for the BTU newsletter!
FASPlint FullBody® Vacuum Splint & & CombiCarrier II Backboard
The Fasplint Fullbody™ splint provides fast, effective and comfortable vacuum immobilization at a budget-friendly price. With its seamless plastic construction, the CombiCarrier II is easy to clean and disinfect. Foam filling makes it ideal for water rescue.
Recertified Lifepak 12 12-Lead Biphasic Defibrillators
The Lifepak 12 Defibrillator/Monitor is a multi-parameter device that combines semi-automated and manual defibrillation with capnography, external pacing, 12-lead electrocardiography and other monitoring functions.
Curaplex Fentanyl PPE Kits
The Curaplex Fentanyl Protection Kits serve to protect emergency caregivers from potential exposure to dangerous substances, as well as provide products for use in an overdose situation.
September 4, 2012
Publicly available naloxone: Benefits outweigh the risks
This article is getting some interesting comments by industry professionals. I've commented previously on public access to naloxone, the narcotic antagonist used for heroin and other narcotic-based overdoses.
Since the introduction of the intranasal route of administration, the opportunity for EMS personnel other than paramedics to administer it as well as the general public has made its use increasingly controversial.
This is how I see it:
1) Naloxone is a very safe medication. Given properly, the risk of adverse side effects is minimal. The intranasal route is relatively slow compared to intravenous injection, making for a more controlled uptake.
2) During the past 20 years, we have seen technological evolution bring previously "advanced" procedures to the masses. Public-access AEDs is one example. Epinephrine autoinjectors is another.
3) An AED is to a cardiac arrest what naloxone is to a narcotic overdose. Its effectiveness is time-based. The sooner it can be administered, the better the chances of reversing respiratory depression and preventing subsequent cardiac arrest. We are unable to be in all places at all times, so why not give the victim an opportunity to survive that mistake?
4) No data currently exist to suggest that having an antidote freely available will increase the frequency of illicit narcotic use.
It will be interesting to see where this will go. At least to me, the benefits outweigh the risk.